PeptideAgentAsk PeptideAgent
Peptide guide · Growth Hormone

CJC-1295: the evidence, status, and research questions.

CJC-1295 guide to human and preclinical evidence, research uses, FDA status, sport status, primary sources, and key limits.

Published Evidence reviewed August 7, 20262 inspectable sources7 min read
01What is CJC-1295?02What is the evidence for CJC-1295?03What is CJC-1295 being studied for?04Is CJC-1295 FDA approved?05Is CJC-1295 prohibited in sport?06What are the evidence limits for CJC-1295?

EVIDENCE TAKEAWAY

The short answer.

CJC-1295 can produce measurable endocrine effects, but biomarker changes should not be confused with proven improvement in health outcomes.

WHAT IS CJC-1295?

Start with identity.

A long-acting growth hormone-releasing hormone analog studied in early human pharmacology research.

Entity type
Peptide analog
Research category
Growth Hormone
Names and aliases
CJC-1295

HUMAN VS PRECLINICAL

What evidence exists for CJC-1295?

HUMAN EVIDENCE
2/5 · Early human pharmacology

Small studies measured hormone responses; they do not establish long-term therapeutic outcomes.

PRECLINICAL EVIDENCE
3/5 · Mechanism established

Long-acting GHRH analog activity is established, while clinical benefit remains uncertain.

RESEARCH INTENT

What is CJC-1295 being studied for?

Current source-backed research areas include the topics below. Inclusion means the area is being investigated; it does not establish a treatment benefit.

  • 01Growth hormone secretion
  • 02IGF-1
  • 03GHRH pharmacology
  • 04Long-acting analogs

U.S. REGULATORY STATUS

Is CJC-1295 FDA approved?

No FDA-approved drug product.

SPORT STATUS

Is CJC-1295 prohibited in sport?

Prohibited at all times under the 2026 WADA List (S2).

Anti-doping rules and product ingredients can change. Athletes should verify the current official list and the exact product before making a real decision.

EVIDENCE LIMITS

What can the current record not establish?

COMMON SEARCH INTENTS

Reviewed questions about CJC-1295.

Evidence

What is the evidence for CJC-1295?

CJC-1295 can produce measurable endocrine effects, but biomarker changes should not be confused with proven improvement in health outcomes.

2 sources Research

What is CJC-1295 being studied for?

Current source-backed research areas include Growth hormone secretion, IGF-1, GHRH pharmacology, Long-acting analogs. These areas describe investigation, not established personal benefit.

2 sources FDA status

Is CJC-1295 FDA approved?

Current U.S. status for CJC-1295: No FDA-approved drug product.

2 sources Sport status

Is CJC-1295 prohibited in sport?

Current sport-status snapshot for CJC-1295: Prohibited at all times under the 2026 WADA List (S2).

2 sources Evidence limits

What are the main evidence limits for CJC-1295?

Marketed CJC-1295 products may differ in structure, including whether a drug-affinity complex is present.

2 sources

PRIMARY AND OFFICIAL SOURCES

Inspect the research behind this guide.